课题基金 / 基金详情

Diagnostic and Predictive Utility of Serum Biomarkers and Magnetic Resonance Imaging Predictors for Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis

Diagnostic and Predictive Utility of Serum Biomarkers and Magnetic Resonance Imaging Predictors for Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis
血清生物标志物和磁共振成像预测因子对复发缓解型多发性硬化症患者认知障碍的诊断和预测效用
批准号：
486263
负责人：
Sahoo Saswat
金额：
$1.27万
依托单位：
University of Alberta
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
已结题
起止时间：
2022-12-01 至 2023-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=486263&lang=en
关键词：
Biomarkers Cognitive Impairment Glial Fibrillary Acidic Protein Humans Imaging Biomarkers Magnetic Resonance Imaging Multiple Sclerosis Neurofilament Light Chain Relapsing-Remitting Multiple Sclerosis Serum Biomarkers

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
认知障碍（CI）是多发性硬化症（MS）的一种临床表现，与其他症状相比，很少受到关注。人们对通过简单地测量特定值来检测当前和未来的CI越来越感兴趣
英文摘要
Cognitive impairment (CI) is a clinical manifestation of Multiple Sclerosis (MS) that has received little attention compared to its other symptoms. There has been a growing interest in being able to detect current and future CI by simply measuring specifi
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金